ArticleBritish journal of cancer2020

Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC.

Chao Rong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.